Validation of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis

R Bergamaschi, S Minguzzi, MP Amato…�- Functional�…, 2009 - search.proquest.com
Swallowing problems can complicate the course of multiple sclerosis (MS). However, no
validated questionnaire for the assessment of dysphagia in MS is currently available. We …

Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS study

…, MG Palmieri, R Manni, M Terzaghi, R Bergamaschi…�- Sleep, 2008 - academic.oup.com
Study Objectives: To verify the existence of a symptomatic form of restless legs syndrome (RLS)
secondary to multiple sclerosis (MS) and to identify possible associated risk factors. …

Multiple sclerosis progression and relapse activity in children

…, C Pozzilli, S Romano, P Gallo, R Bergamaschi…�- JAMA�…, 2024 - jamanetwork.com
Importance Although up to 20% of patients with multiple sclerosis (MS) experience onset
before 18 years of age, it has been suggested that people with pediatric-onset MS (POMS) are …

Morbidity of thyroid surgery

R Bergamaschi, G Becouarn, J Ronceray…�- The American journal of�…, 1998 - Elsevier
Background: Morbidity is today’s concern in thyroid surgery. The purpose of this paper was
to quantify risk factors’ contribution to morbidity rates. Methods: During 50 months, 1,163 …

Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica

A Ghezzi, R Bergamaschi, V Martinelli, M Trojano…�- Journal of�…, 2004 - Springer
Objectives: To evaluate the clinical characteristics, course and prognosis of Devic’s neuromyelitis
optica (DNO), to evaluate the prognostic role of demographic and clinical features, to …

Association of initial disease-modifying therapy with later conversion to secondary progressive multiple sclerosis

…, P Duquette, M Trojano, A Lugaresi, R Bergamaschi…�- Jama, 2019 - jamanetwork.com
Importance Within 2 decades of onset, 80% of untreated patients with relapsing-remitting
multiple sclerosis (MS) convert to a phase of irreversible disability accrual termed secondary …

Laparoscopic sigmoid resection for diverticulitis decreases major morbidity rates: a randomized control trial: short-term results of the Sigma Trial

BR Klarenbeek, AA Veenhof, R Bergamaschi… - 2009 - journals.lww.com
Background: No randomized controlled trial has compared laparoscopic sigmoid resection (LSR)
to open sigmoid resection (OSR) for symptomatic diverticulitis of the sigmoid colon. …

Defining secondary progressive multiple sclerosis

…, C Boz, E Pucci, J Lechner-Scott, R Bergamaschi…�- Brain, 2016 - academic.oup.com
A number of studies have been conducted with the onset of secondary progressive multiple
sclerosis as an inclusion criterion or an outcome of interest. However, a standardized …

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial�…

…, A Achiron, D Karussis, R Bergamaschi…�- The Lancet�…, 2018 - thelancet.com
Background Although several disease-modifying treatments are available for relapsing multiple
sclerosis, treatment effects have been more modest in progressive multiple sclerosis and …

[HTML][HTML] Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica

…, H Appelhans, D Franciotta, R Bergamaschi…�- PLoS�…, 2007 - journals.plos.org
Background Neuromyelitis optica (NMO) is a demyelinating disease of the central nervous
system (CNS) of putative autoimmune aetiology. Early discrimination between multiple …